Praxis Precision Medicines, Inc.
PRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689548
No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Praxis Precision Medicines, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +22 vs. Q2 2024
- Shares held
- 18.9M
- +1.74M (+10.1%) vs. Q2 2024
- Total value
- $1.09B
- +$382.6M (+54.0%) vs. Q2 2024
- New holders
- 35
- 43 more added
- Sold out
- 13
- 45 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 309 | $11.3B |
| Q1 2026 | 291 | $10.2B |
| Q4 2025 | 250 | $8.69B |
| Q3 2025 | 152 | $1.31B |
| Q2 2025 | 144 | $1.02B |
| Q1 2025 | 150 | $889.3M |
| Q4 2024 | 162 | $1.67B |
| Q3 2024 | 134 | $1.09B |
| Q2 2024 | 113 | $762.1M |
| Q1 2024 | 111 | $971.3M |
| Q4 2023 | 60 | $178.6M |
| Q3 2023 | 74 | $195.6M |
| Q2 2023 | 78 | $134.6M |
| Q1 2023 | 87 | $43.1M |
| Q4 2022 | 104 | $108.1M |
| Q3 2022 | 108 | $95.7M |
| Q2 2022 | 95 | $105.5M |
| Q1 2022 | 103 | $463.4M |
| Q4 2021 | 100 | $863.1M |
| Q3 2021 | 93 | $791.5M |
| Q2 2021 | 80 | $751.0M |
| Q1 2021 | 68 | $1.19B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Praxis Precision Medicines, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 130,000 | $7.48M | 1.20% | −130,000−50.0% | Reduced |
| Charles Schwab Investment Management Inc | 137,052 | $7.89M | 0.00% | +89,578+188.7% | Added |
| Northern Trust Corp | 152,267 | $8.76M | 0.00% | +104,198+216.8% | Added |
| Sphera Funds Management Ltd. | 152,307 | $8.76M | 1.43% | −131,117−46.3% | Reduced |
| Candriam Luxembourg S.C.A. | 162,031 | $9.32M | 0.05% | +162,031 | New |
| Driehaus Capital Management LLC | 166,056 | $9.55M | 0.08% | −98,632−37.3% | Reduced |
| Marshall Wace, LLP | 170,095 | $9.79M | 0.01% | −78,286−31.5% | Reduced |
| StemPoint Capital LP | 174,034 | $10.0M | 3.00% | +144,775+494.8% | Added |
| PFM Health Sciences, LP | 183,092 | $10.5M | 0.60% | −270,054−59.6% | Reduced |
| Wellington Management Group LLP | 219,907 | $12.7M | 0.00% | +168,394+326.9% | Added |
| CIBC Asset Management Inc | 248,939 | $14.3M | 0.05% | +56,272+29.2% | Added |
| Soleus Capital Management, L.P. | 259,398 | $14.9M | 1.24% | −273,617−51.3% | Reduced |
| FMR LLC | 273,895 | $15.8M | 0.00% | −17,084−5.9% | Reduced |
| Goldman Sachs Group Inc | 279,620 | $16.1M | 0.00% | +148,623+113.5% | Added |
| Nuveen Asset Management, LLC | 304,827 | $17.5M | 0.00% | +130,160+74.5% | Added |
| Baker Bros. Advisors LP | 323,105 | $18.6M | 0.19% | +191,572+145.6% | Added |
| 5AM Venture Management, LLC | 340,000 | $19.6M | 4.04% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 350,666 | $20.2M | 21.90% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 368,000 | $21.2M | 3.11% | −47,000−11.3% | Reduced |
| Geode Capital Management, LLC | 398,838 | $23.0M | 0.00% | +3,779+1.0% | Added |
| Janus Henderson Group PLC | 523,566 | $30.1M | 0.02% | +141,881+37.2% | Added |
| Franklin Resources Inc | 445,233 | $31.2M | 0.01% | +205,335+85.6% | Added |
| Verition Fund Management LLC | 559,151 | $32.2M | 0.22% | −189,169−25.3% | Reduced |
| VR Adviser, LLC | 706,131 | $40.6M | 2.13% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 761,955 | $43.8M | 0.51% | −473,644−38.3% | Reduced |
| State Street Corp | 789,624 | $45.4M | 0.00% | −29,518−3.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 854,083 | $49.1M | 0.09% | −280,000−24.7% | Reduced |
| Cormorant Asset Management, LP | 870,000 | $50.1M | 2.65% | +185,000+27.0% | Added |
| Capital Research Global Investors | 997,094 | $57.4M | 0.01% | +997,094 | New |
| Point72 Asset Management, L.P. | 1,033,244 | $59.5M | 0.21% | −18,457−1.8% | Reduced |
| Vanguard Group Inc | 1,038,994 | $59.8M | 0.00% | +61,849+6.3% | Added |
| Price T Rowe Associates Inc | 1,120,080 | $64.5M | 0.01% | +181,501+19.3% | Added |
| Perceptive Advisors LLC | 1,164,035 | $67.0M | 1.44% | +413,805+55.2% | Added |
| BlackRock, Inc. | 1,302,435 | $74.9M | 0.00% | +1,302,435 | New |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −389,546−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −75,433−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −75,319−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −16,328−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,321−100.0% | Sold out |
| Ballentine Partners, LLC | 0 | $0 | 0.00% | −10,911−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −6,765−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −6,368−100.0% | Sold out |
| Windmill Hill Asset Management Ltd | 0 | $0 | 0.00% | −5,268−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −1,105−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |